1
|
Barfett J, Velauthapillai N, Kloeters C, Mikulis DJ, Jaskolka JD. An en bloc approach to CT perfusion for the evaluation of limb ischemia. Int J Cardiovasc Imaging 2013; 28:2073-83. [PMID: 22286394 DOI: 10.1007/s10554-011-9978-z] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/10/2011] [Accepted: 11/03/2011] [Indexed: 01/01/2023]
Abstract
We examine volumetric CT perfusion in soft tissues of the entire foot with an en bloc technique to provide a meaningful measure of differentiation between mild and major vascular impairment. With Institutional Review Board approval, 22 healthy male subjects between the ages of 21 and 50 (mean 37) were enrolled. Volumetric computed tomography using an en bloc technique was conducted on 14 subjects for validation while unilateral vascular obstruction was simulated in the calves of the remaining 8 subjects. Perfusion estimates were made using in-house software and differences in perfusion estimates between feet were evaluated with Student's t-test at 95% confidence. Subjects with simulated major vascular obstruction (calf blood pressure cuff inflated to 200 mmHg) showed significantly higher ratios of perfusion estimates between the unobstructed and obstructed foot compared to subjects with simulated mild vascular obstruction (cuff inflated to 120 mmHg), mean 4.6, SD 2.6 vs. mean 1.3, SD 0.2; P = 0.05. CT perfusion using an en bloc technique shows promise for the future evaluation of patients with critical limb ischemia and particularly for re-characterization post medical, surgical or endovascular intervention.
Collapse
Affiliation(s)
- Joe Barfett
- Medical Imaging, University Health Network, 399 Bathurst St., McLaughlin Pavilion, 3rd Floor Rm 431, Toronto, ON, M5T 2S8, Canada.
| | | | | | | | | |
Collapse
|
2
|
Wiart M, Curiel L, Gelet A, Lyonnet D, Chapelon JY, Rouvière O. Influence of perfusion on high-intensity focused ultrasound prostate ablation: a first-pass MRI study. Magn Reson Med 2007; 58:119-127. [PMID: 17659632 DOI: 10.1002/mrm.21271] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Our aim was to evaluate the influence of regional prostate blood flow (rPBF) on high-intensity focused ultrasound (HIFU) treatment outcome. A total of 48 patients with clinically localized prostate cancer were examined by dynamic contrast-enhanced (DCE)-MRI prior to HIFU therapy. A prostate-specific antigen (PSA) nadir threshold of 0.2 ng/ml was used to define the populations of responders and nonresponders. A dedicated tracer kinetic model, namely "monoexponential plus constant" (MPC) deconvolution, was implemented to provide quantitative estimates of rPBF. The results were compared with those obtained by semiquantitative (steepest slope, mean gradient) and quantitative (Fermi deconvolution) approaches. Of the four methods studied, quantitative rPBF obtained by MPC deconvolution proved the most sensitive to the perfusion changes encountered in this study. Furthermore, blood-flow values obtained with MPC deconvolution in the prostate and muscle (12 +/- 8 and 5 +/- 3 ml/min/100 g, respectively) were in good agreement with literature data. The mean pretreatment rPBF obtained with MPC deconvolution was significantly higher in nonresponders compared to responders (16 +/- 9 vs. 10 +/- 6 ml/min/100 g), suggesting a correlation between baseline perfusion and treatment outcome. The present work describes and validates the use of dynamic MRI to estimate rPBF in patients, which in the future may help to refine the conduct of HIFU therapy.
Collapse
Affiliation(s)
- Marlène Wiart
- Université de Lyon, Lyon, F-69003, France; INSA de Lyon, Villeurbanne, F-69621, France; Creatis CNRS, UMR 5220, Bron, F-69677, France; Inserm, U630, Bron, F-69677, France
| | - Laura Curiel
- Université de Lyon, Lyon, F-69003, France; Inserm, U556, Lyon, F-69424, France
| | - Albert Gelet
- Université de Lyon, Lyon, F-69003, France; Inserm, U556, Lyon, F-69424, France
- Université de Lyon, Lyon, F-69003, France; Hospices Civils de Lyon, Edouard Herriot Hospital, Urology Department, Lyon, F-69003, France
| | - Denis Lyonnet
- Université de Lyon, Lyon, F-69003, France; Inserm, U556, Lyon, F-69424, France
- Université de Lyon, Lyon, F-69003, France; Université de Lyon 1, Faculté de Médecine Lyon Nord, Lyon, F-69003, France
- Université de Lyon, Lyon, F-69003, France; Hospices Civils de Lyon, Edouard Herriot Hospital, Department of Urinary and Vascular Imaging, Lyon, F-69003, France
| | - Jean-Yves Chapelon
- Université de Lyon, Lyon, F-69003, France; Inserm, U556, Lyon, F-69424, France
| | - Olivier Rouvière
- Université de Lyon, Lyon, F-69003, France; Inserm, U556, Lyon, F-69424, France
- Université de Lyon, Lyon, F-69003, France; Université de Lyon 1, Faculté de Médecine Lyon Nord, Lyon, F-69003, France
- Université de Lyon, Lyon, F-69003, France; Hospices Civils de Lyon, Edouard Herriot Hospital, Department of Urinary and Vascular Imaging, Lyon, F-69003, France
| |
Collapse
|